(Reuters) - Tesla Inc is cutting several thousand jobs across the company as it seeks to reduce costs and become sustainably profitable without endangering the critical ramp up of production of its Model 3 sedan.
NEW YORK (Reuters) - U.S. stocks were near flat on Tuesday as investors became cautious ahead of the Federal Reserve's policy decision, while a historic U.S.-North Korea summit failed to impress investors.
NEW YORK (Reuters) - World stock markets were little changed on Tuesday while the U.S. dollar rose slightly against a basket of major currencies, with only muted impact from the long-awaited U.S.-North Korea summit aimed at denuclearizing the Korean peninsula.
NEW YORK (Reuters) - New York's highest court on Tuesday curbed the state attorney general's ability to fight fraud on Wall Street, awarding a victory to Credit Suisse Group AG as it tries to end an $11 billion lawsuit over risky mortgage securities.
NEW YORK (Reuters) - A Mexican real estate developer has filed a $1.2 billion lawsuit accusing JPMorgan Chase & Co of fraudulently inducing it to transfer properties based on a false promise it would sell them.
NEW YORK (Reuters) - Morgan Stanley Chief Executive Officer James Gorman called the bank's fixed-income group its "most attractive business" on Tuesday at a conference the Wall Street firm held in New York.
WASHINGTON (Reuters) - The U.S. government had a $147 billion budget deficit in May, an increase of 66 percent from the same month last year as the ledger took a hit from declining revenue and higher spending, according to Treasury Department data released on Tuesday.
NEW YORK (Reuters) - Union leaders plan to meet with General Electric Co on Wednesday in a bid to avert closure of a Virginia factory that makes controls for GE's power plants, the company and the union said on Tuesday.
LONDON (Reuters) - WPP's decision to allow founder Martin Sorrell to quit with share awards worth millions of pounds faced fresh opposition on Tuesday as Hermes EOS advised shareholders to vote against the advertising giant's remuneration report.
Investors are speculating on a possible $58 bln deal by artificial-joint maker Stryker to buy Boston Scientific. After a string of big device mergers, Rob Cyran says any bid would get close antitrust scrutiny — and invite others to do deals before it's too late.